Analysts forecast that Prestige Consumer Healthcare Inc (NYSE:PBH) will post earnings per share (EPS) of $0.64 for the current quarter, Zacks reports. Four analysts have made estimates for Prestige Consumer Healthcare’s earnings. The lowest EPS estimate is $0.62 and the highest is $0.65. Prestige Consumer Healthcare posted earnings per share of $0.68 during the same quarter last year, which would indicate a negative year over year growth rate of 5.9%. The company is scheduled to announce its next quarterly earnings report before the market opens on Thursday, August 1st.

On average, analysts expect that Prestige Consumer Healthcare will report full-year earnings of $2.81 per share for the current financial year, with EPS estimates ranging from $2.80 to $2.82. For the next financial year, analysts forecast that the business will report earnings of $2.95 per share, with EPS estimates ranging from $2.89 to $2.99. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research firms that follow Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, May 9th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.02. The business had revenue of $241.03 million for the quarter, compared to analyst estimates of $237.22 million. Prestige Consumer Healthcare had a positive return on equity of 12.45% and a negative net margin of 3.67%. Prestige Consumer Healthcare’s quarterly revenue was down 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.

A number of equities research analysts recently weighed in on the company. ValuEngine lowered Intersect ENT from a “buy” rating to a “hold” rating in a research report on Monday. TheStreet lowered USD Partners from a “b-” rating to a “c+” rating in a research report on Friday, May 10th. CIBC reiterated a “hold” rating and issued a $84.00 price target on shares of Prestige Consumer Healthcare in a research report on Monday, May 27th. Royal Bank of Canada reiterated a “buy” rating and issued a $97.00 price target on shares of Prestige Consumer Healthcare in a research report on Friday, March 15th. Finally, Zacks Investment Research lowered Hanger from a “hold” rating to a “sell” rating in a research report on Tuesday, May 28th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $57.77.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in PBH. Diversified Trust Co grew its holdings in Prestige Consumer Healthcare by 8.2% during the second quarter. Diversified Trust Co now owns 8,575 shares of the company’s stock valued at $272,000 after purchasing an additional 650 shares during the period. Primecap Management Co. CA raised its position in Prestige Consumer Healthcare by 51.6% during the first quarter. Primecap Management Co. CA now owns 42,600 shares of the company’s stock valued at $1,274,000 after purchasing an additional 14,500 shares in the last quarter. Champlain Investment Partners LLC raised its position in Prestige Consumer Healthcare by 2.2% during the first quarter. Champlain Investment Partners LLC now owns 2,088,940 shares of the company’s stock valued at $62,480,000 after purchasing an additional 44,975 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Prestige Consumer Healthcare by 10.3% during the first quarter. The Manufacturers Life Insurance Company now owns 874,566 shares of the company’s stock valued at $26,158,000 after purchasing an additional 81,568 shares in the last quarter. Finally, AJO LP raised its position in Prestige Consumer Healthcare by 22.6% during the first quarter. AJO LP now owns 144,056 shares of the company’s stock valued at $4,309,000 after purchasing an additional 26,560 shares in the last quarter.

PBH stock traded down $0.01 during midday trading on Friday, reaching $30.96. 420,100 shares of the stock were exchanged, compared to its average volume of 502,133. The company has a market cap of $1.59 billion, a PE ratio of 11.15, a PEG ratio of 1.76 and a beta of 0.93. Prestige Consumer Healthcare has a 52 week low of $26.25 and a 52 week high of $41.76. The company has a quick ratio of 1.43, a current ratio of 2.37 and a debt-to-equity ratio of 1.64. The firm has a fifty day moving average of $30.65.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Recommended Story: The benefits and drawbacks of dollar cost averaging

Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.